Photo from Paolo Tarantino/Twitter
Jun 28, 2023, 17:38
ADCs keep showing impressive activity across cancers – Paolo Tarantino
ADCs keep showing impressive activity across cancers. 1L EV+pembro led to 64% ORR among patients with advanced urothelial cancer. Still, the 3.9% rate of fatal TRAEs calls for strategies to optimize the toxicities of ADCs, particularly when used in combos.
For details: Click here
Source: Paolo Tarantino/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14